Vaccine evaluation studies performed in Korea from 2000 to 2014
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cha, J. | - |
dc.contributor.author | Kim, H.W. | - |
dc.contributor.author | Lee, S. | - |
dc.contributor.author | Cho, H.K. | - |
dc.contributor.author | Ahn, J.G. | - |
dc.contributor.author | Kim, K.-H. | - |
dc.date.available | 2020-02-28T03:43:11Z | - |
dc.date.created | 2020-02-12 | - |
dc.date.issued | 2016 | - |
dc.identifier.issn | 2384-1079 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/8769 | - |
dc.description.abstract | Purpose: Vaccine evaluation studies were initiated from 2000 by the Ministry of Food and Drug Safety to produce proper data about the safety and immunogenicity of vaccines. The purpose of this study was to review studies and reports on evaluation of vaccine such as immunogenicity, efficacy, effectiveness, safety and other related topics in order to find and analyze the data on the usefulness of each vaccine. Methods: From 2000 to 2014, the project The vaccine evaluation had been performed by several researchers, and studies and reports of vaccine evaluation. We reviewed the results and outcomes of studies regarding the evaluation of vaccine’s usefulness and analyzed the possibilities of applying these data for establishing vaccine policies. For each vaccine, data analysis and organization were done according to evaluation fields. Results: A total of 83 studies were performed on vaccines from 2000 to 2014. For each vaccine, 8 studies were performed on BCG, 14 on DTaP/Td, 1 on poliovirus, 5 on Hib, 3 on pneumococcus, 11 on influenza, 3 on hepatitis A, 11 on MMR, 11 on varicella, and 16 on Japanese encephalitis. All studies were analyzed by the following evaluation area, such as safety, immunogenicity, seroprevalence, persistence of immunity, efficacy, effectiveness, vaccine evaluation methods, quality control product for vaccine, and others. Conclusions: Vaccine evaluation studies performed in Korea may be useful as references for establishing vaccination strategy and policy and could be used as baseline data for future studies on vaccine evaluation, vaccine policy establishment, and public/expert vaccine education in Korea. © 2016, Korean Society of Pediatric Infectious Diseases. All rights reserved. | - |
dc.language | 한국어 | - |
dc.language.iso | ko | - |
dc.publisher | The Korean Society of Pediatric Infectious Diseases | - |
dc.relation.isPartOf | Pediatric Infection and Vaccine | - |
dc.subject | BCG vaccine | - |
dc.subject | chickenpox vaccine | - |
dc.subject | diphtheria pertussis tetanus vaccine | - |
dc.subject | Haemophilus influenzae type b vaccine | - |
dc.subject | hepatitis A vaccine | - |
dc.subject | influenza vaccine | - |
dc.subject | Japanese encephalitis vaccine | - |
dc.subject | measles mumps rubella vaccine | - |
dc.subject | Pneumococcus vaccine | - |
dc.subject | poliomyelitis vaccine | - |
dc.subject | vaccine | - |
dc.subject | Article | - |
dc.subject | clinical effectiveness | - |
dc.subject | evaluation study | - |
dc.subject | immunity | - |
dc.subject | immunogenicity | - |
dc.subject | Korea | - |
dc.subject | quality control | - |
dc.subject | seroprevalence | - |
dc.title | Vaccine evaluation studies performed in Korea from 2000 to 2014 | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.doi | 10.14776/piv.2016.23.2.117 | - |
dc.identifier.bibliographicCitation | Pediatric Infection and Vaccine, v.23, no.2, pp.117 - 127 | - |
dc.identifier.kciid | ART002134127 | - |
dc.identifier.scopusid | 2-s2.0-84985023135 | - |
dc.citation.endPage | 127 | - |
dc.citation.startPage | 117 | - |
dc.citation.title | Pediatric Infection and Vaccine | - |
dc.citation.volume | 23 | - |
dc.citation.number | 2 | - |
dc.contributor.affiliatedAuthor | Cho, H.K. | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Evaluation studies | - |
dc.subject.keywordAuthor | Republic of Korea | - |
dc.subject.keywordAuthor | Vaccines | - |
dc.subject.keywordPlus | BCG vaccine | - |
dc.subject.keywordPlus | chickenpox vaccine | - |
dc.subject.keywordPlus | diphtheria pertussis tetanus vaccine | - |
dc.subject.keywordPlus | Haemophilus influenzae type b vaccine | - |
dc.subject.keywordPlus | hepatitis A vaccine | - |
dc.subject.keywordPlus | influenza vaccine | - |
dc.subject.keywordPlus | Japanese encephalitis vaccine | - |
dc.subject.keywordPlus | measles mumps rubella vaccine | - |
dc.subject.keywordPlus | Pneumococcus vaccine | - |
dc.subject.keywordPlus | poliomyelitis vaccine | - |
dc.subject.keywordPlus | vaccine | - |
dc.subject.keywordPlus | Article | - |
dc.subject.keywordPlus | clinical effectiveness | - |
dc.subject.keywordPlus | evaluation study | - |
dc.subject.keywordPlus | immunity | - |
dc.subject.keywordPlus | immunogenicity | - |
dc.subject.keywordPlus | Korea | - |
dc.subject.keywordPlus | quality control | - |
dc.subject.keywordPlus | seroprevalence | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.